FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2019/06/019754 [Registered on: 19/06/2019] Trial Registered Prospectively
Last Modified On: 20/06/2020
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Drug
Siddha
Other (Specify) [SIDDHAR YOGAM THERAPY]  
Study Design  Other 
Public Title of Study   Clinical trial on trial on eraippu erumal with yoga therapy 
Scientific Title of Study   An open labelled non randomised phase II comparitive clinical trial to evaluate the therapeutic efficacy of SIDDHAR YOGAM THERAPY and KHARUN THULASI KARPAM (SIDDHA KALPA MEDICINE INTERNAL) for ERAIPPU ERUMAL (BRONCHIAL ASTHMA) 
Trial Acronym   
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  S MUTHU VIGNESH 
Designation  PG Scholar 
Affiliation  Govt Siddha Medical College Hospital 
Address  21C ANNAI INDIRA NAGAR NEAR ANNA STADIUM PALAYAMKOTTAI
PG scholar Dept of siddhar yoga maruthuvam Govt siddha medical college and hospital Palayamkottai
Tirunelveli
TAMIL NADU
627002
India 
Phone  9566757400  
Fax    
Email  am030294@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  A S POONGODIKANTHMATHI 
Designation  PROFESSOR  
Affiliation  Govt Siddha Medical College Hospital 
Address  DEPT OF SIRAPPU MARUTHUVAM GOVT SIDDHA MEDICAL COLLEGE PALAYAMKOTTAI TIRUNELVELI
Dept of siddhar yoga maruthuvam Sirappu maruthuvam Govt siddha medical college and hospital Palayamkottai
Tirunelveli
TAMIL NADU
627002
India 
Phone  9865105356  
Fax    
Email  arunapriya1995@gmail.com  
 
Details of Contact Person
Public Query
 
Name  S MUTHU VIGNESH 
Designation  PG Scholar 
Affiliation  Govt Siddha Medical College Hospital 
Address  21C ANNAI INDIRA NAGAR NEAR ANNA STADIUM PALAYAMKOTTAI
PG scholar Dept of siddhar yoga maruthuvam Govt siddha medical college and hospital Palayamkottai

TAMIL NADU
627002
India 
Phone  9566757400  
Fax    
Email  am030294@gmail.com  
 
Source of Monetary or Material Support  
self funding 
 
Primary Sponsor  
Name  S MUTHU VIGNESH 
Address  21C ANNAI INDIRA NAGAR NEAR ANNA STADIUM PALAYAMKOTTAI 
Type of Sponsor  Other [Govt Siddha Medical college] 
 
Details of Secondary Sponsor  
Name  Address 
Nil  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
S MUTHU VIGNESH  GOVT SIDDHA MEDICAL COLLEGE AND HOSPITAL PALAYAMKOTTAI TIRUNELVELI   Room no 4 Department of siddhar yoga maruthuvam Govt siddha medical college and hospital Palayamkottai
Tirunelveli
TAMIL NADU 
9566757400

am030294@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
IEC Govt Siddha Medical College Palayamkottai  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition: J709||Respiratory conditions due to unspecified external agent,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Comparator Agent  nil  nil 
Intervention  SIDDHAR YOGAM THERAPY WITH SIDDHA KALPA MEDICINE KHARUN THULASI KARPAM  SIDDAR YOGAM THERAPY for 48 days With KHARUN THULASI KARPAM DOSE 1-2Gms od DURATION-48 Days 
 
Inclusion Criteria  
Age From  15.00 Year(s)
Age To  65.00 Year(s)
Gender  Both 
Details  Patient with the symptoms of
Nasal congestion
Rhinorrhea
Tightness of chest
Recurrent attacks of dyspnoea
Cough with expectoration
Wheezing added sound (Rhonchi)
H/O allergy, sneezing.
Patients who are willing to take radiological investigation and provide blood for lab investigation.

 
 
ExclusionCriteria 
Details  Patient with
Age group less than 15 and above 65 years
Systemic Hypertension
Cardiac disease
Renal disease
Tuberculosis
Chronic Bronchitis
Status Asthmaticus
Auto immune disease


 
 
Method of Generating Random Sequence   Not Applicable 
Method of Concealment   Not Applicable 
Blinding/Masking   Open Label 
Primary Outcome  
Outcome  TimePoints 
Before and after treatment measurements of HR/PR/RR/BP will give the efficacy data
Hopefully helps to know about the comparative therapeutic efficacy data 
Group I - Intermittent siddhar yogam therapy within 48 days
Ist sitting 50 percentage of symptoms will reduce
IInd sittind 80 percentage of symptoms will reduce
Group II after giving internal medicine for 48 days 40 percentage of symptoms will reduce
After giving both internal and external yoga therapy for 48 days 80 percentage of symptoms will reduce 
 
Secondary Outcome  
Outcome  TimePoints 
Before and after treatment measurements of HR/PR/RR/BP will give the efficacy data
Hopefully helps to know about the comparative therapeutic efficacy data 
Group I - Intermittent siddhar yogam therapy within 48 days
Ist sitting 50 percentage of symptoms will reduce
IInd sittind 80 percentage of symptoms will reduce
Group II after giving internal medicine for 48 days 40 percentage of symptoms will reduce
After giving both internal and external yoga therapy for 48 days 80 percentage of symptoms will reduce 
 
Target Sample Size   Total Sample Size="40"
Sample Size from India="40" 
Final Enrollment numbers achieved (Total)= "40"
Final Enrollment numbers achieved (India)="40" 
Phase of Trial   Phase 2 
Date of First Enrollment (India)   24/06/2019 
Date of Study Completion (India) 24/03/2020 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Date Missing 
Estimated Duration of Trial   Years="1"
Months="0"
Days="0" 
Recruitment Status of Trial (Global)
Modification(s)  
Not Applicable 
Recruitment Status of Trial (India)  Completed 
Publication Details   Nil 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Brief Summary  

Bronchial asthma is a very common disease in the society due to increasing exposure to air pollution and western life style.It is common in both sex but more prevalent among males, while during adolescence and adulthood,it affects girls and women more.
            Bronchial Asthma (from the Greek-Panting) is a chronic inflammatory disease which produces bronchial hypersensitivity characterised by reversible airway obstruction, mucosal oedema, constriction of the bronchial musculature and excessive secretion of viscid mucus,causing mucous plugs.


 
Close